5.0000
0.0000
(0.00%)
As of 12:20:05 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
7,978,000.0000
5,117,000.0000
7,093,000.0000
5,089,000.0000
4,903,000.0000
Investing Cash Flow
-2,426,000.0000
-3,517,000.0000
-2,381,000.0000
855,000.0000
-4,073,000.0000
Financing Cash Flow
-7,522,000.0000
-679,000.0000
-4,220,000.0000
-5,645,000.0000
423,000.0000
End Cash Position
4,845,000.0000
5,907,000.0000
5,171,000.0000
4,564,000.0000
4,191,000.0000
Capital Expenditure
-2,675,000.0000
-2,751,000.0000
-2,949,000.0000
-2,611,000.0000
-2,418,000.0000
Issuance of Capital Stock
--
23,000.0000
15,000.0000
--
--
Issuance of Debt
10,724,000.0000
16,284,000.0000
6,631,000.0000
6,592,000.0000
10,891,000.0000
Repayment of Debt
-16,214,000.0000
-13,031,000.0000
-7,605,000.0000
-9,044,000.0000
-6,424,000.0000
Free Cash Flow
5,303,000.0000
2,366,000.0000
4,144,000.0000
2,478,000.0000
2,485,000.0000
12/31/2020 - 11/2/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CMOPF Cosmo Pharmaceuticals N.V.
66.93
0.00%
GILD34.SA Gilead Sciences, Inc.
274.00
+0.37%
JNJd.XC
600436.SS PIENTZEHUANG
209.16
+2.03%
SNW.F Sanofi
94.96
-0.15%
SNW.HM Sanofi SA
95.03
-0.20%
BIIB34.SA Biogen Inc.
151.21
-0.59%
GS71.DE GSK plc
15.72
-1.47%
COPNz.XC
ZEG.DE AstraZeneca PLC
128.15
-0.66%